RAD001: A CLINICO-BIOLOGICAL PHASE I GOELAMS TRIAL OF EVEROLIMUS ASSOCIATION WITH HIGH DOSE CHEMOTHERAPY IN LATE RELAPSING AML PATIENTS UNDER 65 YEARS OF AGE

被引：0

作者：

Park, S. ^{[1
]}

Chapuis, N. ^{[1
]}

Saint-Marcoux, F. ^{[1
]}

Recher, C. ^{[2
]}

Demur, C. ^{[2
]}

Vey, N. ^{[3
]}

Prebet, T. ^{[3
]}

Chevallier, P. ^{[4
]}

Cahn, J. Y. ^{[5
]}

Pigneux, A. ^{[6
]}

Lioure, B. ^{[7
]}

Witz, F. ^{[8
]}

Lamy, T. ^{[9
]}

Merlat, A. ^{[10
]}

Delepine, R. ^{[11
]}

Lacombe, C. ^{[1
]}

Mayeux, P. ^{[1
]}

Dreyfus, F. ^{[1
]}

Bene, M. C. ^{[8
]}

Ifrah, N. ^{[12
]}

Bouscary, D. ^{[1
]}

机构：

[1] Hop Cochin, Paris, France

[2] CHU Purpan, Toulouse, France

[3] IPC, Marseille, France

[4] CHU Nantes, Nantes, France

[5] CHU Grenoble, Grenoble, France

[6] CHU Bordeaux, Bordeaux, France

[7] CHU Strasbourg, Strasbourg, France

[8] CHU Nancy, Nancy, France

[9] CHU Rennes, Rennes, France

[10] Novartis, Paris, France

[11] CHU Tours, Tours, France

[12] CHU Angers, Angers, France

来源：

HAEMATOLOGICA | 2012年 / 97卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1136

引用

页码：469 / 469

页数：1

共 4 条

[1] RAD001: A Clinico-Biological Phase I GOELAMS trial of Everolimus Association with High Dose Chemotherapy in Late Relapsing AML Patients Under 65 Years of Age
Park, Sophie
Chapuis, Nicolas
Saint Marcoux, Franck
Recher, Christian
Vey, Norbert
Prebet, Thomas
Chevallier, Patrice
Cahn, Jean-Yves
Pigneux, Arnaud
Lioure, Bruno
Witz, Francis
Lamy, Thierry
Merlat, Annabelle
Delepine, Roselyne
Dreyfus, Francois
Bene, Marie-christine
Ifrah, Norbert
Bouscary, Didier
BLOOD, 2011, 118 (21) : 430 - 431
[2] A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapse
Park, S.
Chapuis, N.
St Marcoux, F.
Recher, C.
Prebet, T.
Chevallier, P.
Cahn, J-Y
Leguay, T.
Bories, P.
Witz, F.
Lamy, T.
Mayeux, P.
Lacombe, C.
Demur, C.
Tamburini, J.
Merlat, A.
Delepine, R.
Vey, N.
Dreyfus, F.
Bene, M. C.
Ifrah, N.
Bouscary, D.
LEUKEMIA, 2013, 27 (07) : 1479 - 1486
[3] A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapse
S Park
N Chapuis
F Saint Marcoux
C Recher
T Prebet
P Chevallier
J-Y Cahn
T Leguay
P Bories
F Witz
T Lamy
P Mayeux
C Lacombe
C Demur
J Tamburini
A Merlat
R Delepine
N Vey
F Dreyfus
M C Béné
N Ifrah
D Bouscary
Leukemia, 2013, 27 : 1479 - 1486
[4] Phase I trial of gemcitabine and split-dose cisplatin plus everolimus (RAD001) in patients with advanced urothelial cancer.
Abida, Wassim
Milowsky, Matthew I.
Ostrovnaya, Irina
Gerst, Scott R.
Rosenberg, Jonathan E.
Regazzi, Ashley Marie
McCoy, Asia S.
Boyd, Mariel Elena
Bajorin, Dean F.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)

← 1 →